BR112017008686A2 - uso e método cosmético - Google Patents

uso e método cosmético

Info

Publication number
BR112017008686A2
BR112017008686A2 BR112017008686-7A BR112017008686A BR112017008686A2 BR 112017008686 A2 BR112017008686 A2 BR 112017008686A2 BR 112017008686 A BR112017008686 A BR 112017008686A BR 112017008686 A2 BR112017008686 A2 BR 112017008686A2
Authority
BR
Brazil
Prior art keywords
formula
compound
cosmetic method
aging
skin signs
Prior art date
Application number
BR112017008686-7A
Other languages
English (en)
Other versions
BR112017008686B1 (pt
Inventor
Brossat Maude
Tournier-Couturier Lucie
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Publication of BR112017008686A2 publication Critical patent/BR112017008686A2/pt
Publication of BR112017008686B1 publication Critical patent/BR112017008686B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

a presente invenção está relacionada ao uso cosmético de pelo menos um composto de fórmula (i), pelo menos um dos seus sais de fórmula (ii) ou uma mistura compreendendo pelo menos um composto de fórmula (i) e pelo menos um composto de fórmula (ii): como agente(s) destinado(s) a prevenir e/ou tratar sinais cutâneos de envelhecimento. um método cosmético não-terapêutico para prevenir e/ou tratar sinais cutâneos de envelhecimento usando estes compostos também é abordado.
BR112017008686-7A 2014-10-30 2015-10-30 uso e método cosmético BR112017008686B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1460442 2014-10-30
FR1460442A FR3027797B1 (fr) 2014-10-30 2014-10-30 Utilisation de derives d'acide salicylique lipophiles
PCT/EP2015/075273 WO2016066811A1 (en) 2014-10-30 2015-10-30 Use of lipophilic salicylic acid derivatives

Publications (2)

Publication Number Publication Date
BR112017008686A2 true BR112017008686A2 (pt) 2018-02-27
BR112017008686B1 BR112017008686B1 (pt) 2021-03-09

Family

ID=52102909

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112017008973A BR112017008973A2 (pt) 2014-10-30 2015-10-30 uso cosmético de derivados de ácido salicílico lipofílico
BR112017008686-7A BR112017008686B1 (pt) 2014-10-30 2015-10-30 uso e método cosmético

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR112017008973A BR112017008973A2 (pt) 2014-10-30 2015-10-30 uso cosmético de derivados de ácido salicílico lipofílico

Country Status (9)

Country Link
US (1) US20170266089A1 (pt)
EP (1) EP3212157B1 (pt)
JP (2) JP6661631B2 (pt)
KR (1) KR102108615B1 (pt)
CN (1) CN107072903A (pt)
BR (2) BR112017008973A2 (pt)
ES (1) ES2733305T3 (pt)
FR (1) FR3027797B1 (pt)
WO (1) WO2016066811A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3100452B1 (fr) 2019-09-05 2021-09-17 Oreal Méthode de diagnostic de peaux agées

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0781137B2 (ja) * 1990-01-24 1995-08-30 御木本製薬株式会社 酸化防止剤
JPH0436238A (ja) * 1990-06-01 1992-02-06 Takasago Internatl Corp 尋常性▲ざ▼瘡用皮膚外用剤
JPH05255063A (ja) * 1992-03-11 1993-10-05 Shiseido Co Ltd 皮膚外用剤
DK0616799T3 (da) * 1993-03-24 2000-09-18 Collaborative Lab Inc Kosmetisk applikationssystem for salicylsyre og fremgangsmåde til fremstilling heraf
JPH06329536A (ja) * 1993-05-21 1994-11-29 Mikimoto Pharmaceut Co Ltd 活性酸素抑制剤
JPH06329516A (ja) * 1993-05-21 1994-11-29 Mikimoto Pharmaceut Co Ltd 化粧料
JPH06329526A (ja) * 1993-05-21 1994-11-29 Mikimoto Pharmaceut Co Ltd ヒアルロニダーゼ阻害剤
FR2726468B1 (fr) * 1994-11-03 1996-12-13 Oreal Utilisation de derive de l'acide salicylique comme stabilisant d'une emulsion huile-dans-eau
JPH09241675A (ja) * 1996-03-12 1997-09-16 Asahi Chem Ind Co Ltd 界面活性剤
JPH101692A (ja) * 1996-06-18 1998-01-06 Asahi Chem Ind Co Ltd 高機能性界面活性剤
JPH1036883A (ja) * 1996-07-16 1998-02-10 Asahi Chem Ind Co Ltd 皮膚および頭髪洗浄剤組成物
CN101384265A (zh) * 2006-02-16 2009-03-11 帝斯曼知识产权资产管理有限公司 新颖的营养药物性组合物和药物组合物，及其用于治疗、辅助治疗或预防炎性病症的用途
CN102846501A (zh) * 2012-08-14 2013-01-02 王青 银杏酚酸在美白祛斑换肤中的用途

Also Published As

Publication number Publication date
BR112017008686B1 (pt) 2021-03-09
CN107072903A (zh) 2017-08-18
JP2019163338A (ja) 2019-09-26
FR3027797A1 (fr) 2016-05-06
KR102108615B1 (ko) 2020-05-07
US20170266089A1 (en) 2017-09-21
FR3027797B1 (fr) 2020-07-10
ES2733305T3 (es) 2019-11-28
EP3212157A1 (en) 2017-09-06
JP2017533217A (ja) 2017-11-09
EP3212157B1 (en) 2019-04-10
JP6661631B2 (ja) 2020-03-11
BR112017008973A2 (pt) 2017-12-26
WO2016066811A1 (en) 2016-05-06
KR20170057449A (ko) 2017-05-24

Similar Documents

Publication Publication Date Title
PH12019550050A1 (en) Isoxazole analogs as fxr agonists and methods of use thereof
BR112018069220A2 (pt) uso de polipeptídeo que tem atividade de dnase para tratamento de tecidos
CL2018000542A1 (es) Nuevos derivados de fenoximetilo.
BR112017002053A2 (pt) composto de acordo com a fórmula (i), composição farmacêutica, e usos de um composto
BR112018005194A2 (pt) processo de composto antifúngico
CL2016002812A1 (es) Uso de ácido 3-2,3,5,6-tetrafluoro-3-trifluorometoxi-bifenil-4-ilcarbamoil-tiofeno-2-carboxílico para preparar un medicamento útil para tratar una enfermedad ocular que es uveítis, ojo seco o causada por un adenovirus composición formulación.
CL2017001488A1 (es) Benzamidas sustituidas con 1,3–tiazol–2–ilo
BR112017027147A2 (pt) agente estimulante de restauração/crescimento de cabelo
BR112017002221A2 (pt) 2-(morfolin-4-il)-1,7-naftiridinas
BR112016023558A2 (pt) compostos úteis como imunomoduladores
BR112016003201A2 (pt) inibidores de grp94 seletivos e usos dos mesmos
BR112015023760A2 (pt) compostos e composições terapêuticas
BR112015026297A2 (pt) terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer
DOP2016000253A (es) Nuevos compuestos
BR112016027041A8 (pt) combinações farmacêuticas para tratamento do câncer
BR112015021524A2 (pt) derivados de sulfonil quinolina e usos dos mesmos
ECSP16008797A (es) Derivados de heterobicicloaril como inhibidores rorc2 y métodos de uso de los mismos
BR112017023432A2 (pt) Derivados de ácido propiônico tetra- hidronaftiridinila e usos do mesmo
BR112016027043A8 (pt) combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
BR112017004589A2 (pt) composto, composição farmacêutica, método para tratar um paciente, uso de um composto, kit, e método para tratar um distúrbio mediado por proteína smyd
BR112017000520A2 (pt) composto ou sal do mesmo, uso um composto ou de um sal, e, kit.
DOP2016000120A (es) Nuevos inhibidores de dgat2
BR112015022846A2 (pt) uso de um composto para tratar ou prevenir um angioedema mediado pelo receptor b2 da bradicinina e formulação compreendendo o mesmo
BR112017002852A2 (pt) compostos de azetidiniloxifenilpirrolidina
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/10/2015, OBSERVADAS AS CONDICOES LEGAIS.